DE EN
Thomas Reiberger

Thomas Reiberger

Hepatic Microenvironment in Disease Progression and Regression

Publications

2025

Hepatic Recompensation Before Systemic Therapy for Hepatocellular Carcinoma Yields Comparable Survival to Compensated Cirrhosis

Lorenzo Lani, Bernhard Scheiner, Matthias Pinter, Thomas Reiberger.
Liver Int. 2025 Dec;45(12):e70413. doi: 10.1111/liv.70413.
2025

Biomarkers of Extracellular Matrix Remodelling Are Linked to Severity and Outcome of Advanced Chronic Liver Disease

Benedikt Simbrunner, Ida Falk Villesen, Georg Semmler, Lorenz Balcar, Georg Kramer, Joana Almeida Calvão, Benedikt Silvester Hofer, Mathias Jachs, Lukas Hartl, Jurij Maurer, Bernhard Scheiner, Kerstin Zinober, Rodrig Marculescu, Michael Trauner, Morten Karsdal, Thomas Reiberger, Mattias Mandorfer, Diana Julie Leeming.
Aliment Pharmacol Ther. 2025 Oct 12. doi: 10.1111/apt.70407. Online ahead of print.
2025

Impact of Underlying Portal Hypertension on Severity and Course of Acute-On-Chronic Liver Failure

Vlad Taru, Georg Kramer, Benedikt S Hofer, Nina Dominik, Lorenz Balcar, Mathias Schneeweiss-Gleixner, Bogdan Procopet, Michael Trauner, Mattias Mandorfer, Philipp Schwabl, Thomas Reiberger, Benedikt Simbrunner.
Liver Int. 2025 Oct;45(10):e70363. doi: 10.1111/liv.70363.
2025

Loss of Bile Salt Export Pump (Bsep/Abcb11) Ameliorates Toxin-induced Hepatic Fibrosis via Suppression of Hepatocellular Jun Amino-terminal Kinase Signaling and Hepatic Stellate Cell Activation

Claudia D Fuchs, Emmanuel D Dixon, Philipp Königshofer, Thierry Claudel, Veronika Mlitz, Hubert Scharnagl, Tatjana Stojakovic, Thomas Reiberger, Michael Trauner.
Cell Mol Gastroenterol Hepatol. 2025 Sep 12;20(1):101630. doi: 10.1016/j.jcmgh.2025.101630. Online ahead of print.
2025

Molecular patterns of the NO-sGC-cGMP pathway in progressive and regressive liver fibrosis models

Thomas Sorz-Nechay, Ksenia Brusilovskaya, Philipp Königshofer, Benedikt S Hofer, Oleksandr Petrenko, Benedikt Simbrunner, Vlad Taru, Katharina Bonitz, Henriette Horstmeier, Kerstin Zinober, Katharina Regnat, Carolin Lackner, Michael Trauner, Peng Sun, Ines Truebenbach, Stefan G Kauschke, Philipp Schwabl, Thomas Reiberger.
Sci Rep. 2025 Jul 25;15(1):27051. doi: 10.1038/s41598-025-12381-0.
2025

Author's reply: "Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis: New perspectives and recommendations"

Benedikt Silvester Hofer, Thomas Reiberger.
Dig Liver Dis. 2025 Jun;57(6):1350-1351. doi: 10.1016/j.dld.2025.04.022. Epub 2025 May 2.
2025

Author's Reply: "Comment on: Aetiology-specific inflammation patterns in patients and rat models of compensated cirrhosis"

Benedikt Silvester Hofer, Thomas Reiberger.
Dig Liver Dis. 2025 Jun;57(6):1344-1345. doi: 10.1016/j.dld.2025.03.018. Epub 2025 Apr 2.
2024

Inflammation remains a dynamic component of portal hypertension in regressive alcohol-related cirrhosis

Benedikt Silvester Hofer, Benedikt Simbrunner, Philipp Königshofer, Ksenia Brusilovskaya, Oleksandr Petrenko, Vlad Taru, Thomas Sorz-Nechay, Kerstin Zinober, Katharina Regnat, Georg Semmler, Carolin Lackner, Michael Trauner, Mattias Mandorfer, Philipp Schwabl, Thomas Reiberger.
United European Gastroenterol J. 2025 Apr;13(3):317-329. doi: 10.1002/ueg2.12643. Epub 2024 Dec 21.
2024

Metabolomic profiles differentiate between porto-sinusoidal vascular disorder, cirrhosis, and healthy individuals

Georg Semmler, Oleksandr Petrenko, Juanjo Jose Lozano, Sarah Shalaby, Juan I Sánchez-Avila, Nara Marella, Thomas Hannich, Katharina Wöran, Lorenz Balcar, Benedikt Simbrunner, Katharina Lampichler, Behrang Mozayani, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Juan-Carlos García-Pagán, Bernhard Scheiner.
JHEP Rep. 2024 Sep 4;6(12):101208. doi: 10.1016/j.jhepr.2024.101208. eCollection 2024 Dec.
2024

Use of artificial intelligence for liver diseases: A survey from the EASL congress 2024

Laura Žigutytė, Thomas Sorz-Nechay, Jan Clusmann, Jakob Nikolas Kather.
JHEP Rep. 2024 Sep 6;6(12):101209. doi: 10.1016/j.jhepr.2024.101209. eCollection 2024 Dec.